Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.910
+0.020 (0.69%)
At close: Jan 21, 2025, 4:00 PM
2.930
+0.020 (0.69%)
After-hours: Jan 21, 2025, 6:04 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $371.30 million as of January 22, 2025. Its market cap has decreased by -55.32% in one year.
Market Cap
371.30M
Enterprise Value
237.02M
1-Year Change
-55.32%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $371.30M, a decrease of -77.18%. That is a compound annual growth rate of -48.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 371.30M | -0.34% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |